Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure

被引:253
作者
Heineke, Joerg [1 ]
Auger-Messier, Mannix [1 ]
Xu, Jian [1 ]
Sargent, Michelle [1 ]
York, Allen [1 ]
Welle, Stephen [2 ]
Molkentin, Jeffery D. [1 ]
机构
[1] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
atrophy; heart failure; hypertrophy; muscle; skeletal; myocardium; BETA SUPERFAMILY MEMBER; CARDIAC CACHEXIA; EXPRESSION; MICE; GROWTH; MASS; MODEL; CARDIOMYOCYTES; MYOCARDIUM; METABOLISM;
D O I
10.1161/CIRCULATIONAHA.109.882068
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background-Cardiac cachexia is characterized by an exaggerated loss of skeletal muscle, weakness, and exercise intolerance, although the cause of these effects remains unknown. Here, we hypothesized that the heart functions as an endocrine organ in promoting systemic cachexia by secreting peptide factors such as myostatin. Myostatin is a cytokine of the transforming growth factor-beta superfamily that is known to control muscle wasting. Methods and Results-We used a Cre/loxP system to ablate myostatin (Mstn gene) expression in a cell type-specific manner. As expected, elimination of Mstn selectively in skeletal muscle with a myosin light chain 1f (MLC1f)-cre allele induced robust hypertrophy in all skeletal muscle. However, heart-specific deletion of Mstn with an Nkx2.5-cre allele did not alter baseline heart size or secondarily affect skeletal muscle size, but the characteristic wasting and atrophy of skeletal muscle that typify heart failure were not observed in these heart-specific null mice, indicating that myocardial myostatin expression controls muscle atrophy in heart failure. Indeed, myostatin levels in the plasma were significantly increased in wild-type mice subjected to pressure overload-induced cardiac hypertrophy but not in Mstn heart-specific deleted mice. Moreover, cardiac-specific overexpression of myostatin, which increased circulating levels of myostatin by 3- to 4-fold, caused a reduction in weight of the quadriceps, gastrocnemius, soleus, and even the heart itself. Finally, to investigate myostatin as a potential therapeutic target for the treatment of muscle wasting in heart failure, we infused a myostatin blocking antibody (JA-16), which promoted greater maintenance of muscle mass in heart failure. Conclusions-Myostatin released from cardiomyocytes induces skeletal muscle wasting in heart failure. Targeted inhibition of myostatin in cardiac cachexia might be a therapeutic option in the future. (Circulation. 2010;121:419-425.)
引用
收藏
页码:419 / 425
页数:7
相关论文
共 28 条
[1]
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice [J].
Allen, David L. ;
Cleary, Allison S. ;
Speaker, Kristin J. ;
Lindsay, Sarah F. ;
Uyenishi, Jill ;
Reed, Jason M. ;
Madden, Molly C. ;
Mehan, Ryan S. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05) :E918-E927
[2]
Cardiac cachexia [J].
Anker, SD ;
Steinborn, W ;
Strassburg, S .
ANNALS OF MEDICINE, 2004, 36 (07) :518-529
[3]
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[4]
Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[5]
Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[6]
Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO
[7]
2-F
[8]
Transcriptional effects of chronic Akt activation in the heart [J].
Cook, SA ;
Matsui, T ;
Li, L ;
Rosenzweig, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22528-22533
[9]
Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene [J].
Grobet, L ;
Pirottin, D ;
Farnir, F ;
Poncelet, D ;
Royo, LJ ;
Brouwers, B ;
Christians, E ;
Desmecht, D ;
Coignoul, F ;
Kahn, R ;
Georges, M .
GENESIS, 2003, 35 (04) :227-238
[10]
Regulation of muscle mass by myostatin [J].
Lee, SJ .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2004, 20 :61-86